Elastrin Therapeutics
Elastrin Therapeutics Inc. is a biotech startup dedicated to rejuvenating cardiovascular diseases by developing innovative therapies that target the root causes of cardiovascular conditions. The company aims to provide new hope for patients and their families through cutting-edge research and collaborative partnerships.
Industries
Nr. of Employees
small (1-50)
Elastrin Therapeutics
Products
Nanoparticle Therapy
A treatment that uses nanoparticles conjugated with antibodies to target and deliver active agents to damaged elastin in tissues, aiming to restore elasticity in blood vessels and other tissues.
Targeted Chelation Therapy
Uses EDTA-loaded albumin nanoparticles to regress arterial calcification without systemic side effects.
Dual Targeted Therapy
Combines EDTA and PGG-loaded nanoparticles to reverse vascular calcification and aneurysms in rat models.
Pentagalloyl Glucose Delivery
Delivers pentagalloyl glucose via nanoparticles to protect elastic lamina and prevent abdominal aortic aneurysm in rats, and to reverse elastase-induced abdominal aortic aneurysm in mice.
Elastin Synthesis via mRNA
Involves the exogenous delivery of synthetic modified mRNA to induce elastin synthesis in skin and elastin-deficient cells for tissue regeneration.
Nanoparticle Therapy
A treatment that uses nanoparticles conjugated with antibodies to target and deliver active agents to damaged elastin in tissues, aiming to restore elasticity in blood vessels and other tissues.
Targeted Chelation Therapy
Uses EDTA-loaded albumin nanoparticles to regress arterial calcification without systemic side effects.
Dual Targeted Therapy
Combines EDTA and PGG-loaded nanoparticles to reverse vascular calcification and aneurysms in rat models.
Pentagalloyl Glucose Delivery
Delivers pentagalloyl glucose via nanoparticles to protect elastic lamina and prevent abdominal aortic aneurysm in rats, and to reverse elastase-induced abdominal aortic aneurysm in mice.
Elastin Synthesis via mRNA
Involves the exogenous delivery of synthetic modified mRNA to induce elastin synthesis in skin and elastin-deficient cells for tissue regeneration.
Services
R&D services focused on developing therapies that address root causes of cardiovascular conditions, delivered through internal programs and external collaborations.
R&D services focused on developing therapies that address root causes of cardiovascular conditions, delivered through internal programs and external collaborations.
Expertise Areas
- Cardiovascular therapeutics
- Translational / preclinical R&D
- Targeted drug delivery
- Nanoparticle conjugation
Key Technologies
- Nanoparticle-based drug delivery
- Monoclonal antibody conjugation
- Targeted therapeutic design
- Preclinical translational study methods